Xtrackers S&P 500 Swap UCITS ETF 5C EUR Hedged
XS5E.DE
Deutsche Börse- -
EUR
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Xtrackers S&P 500 Swap UCITS ETF (XS5E.DE) is an exchange-traded fund that seeks to track the performance of the S&P 500 Index through a synthetic replication strategy utilizing total return swaps. The ETF provides investors with exposure to large-cap U.S. equities across diverse sectors including technology, healthcare, financials, and consumer discretionary; it offers accumulating share classes that reinvest dividends, daily liquidity on the Xetra exchange, and competitive total expense ratios typical of DWS's Xtrackers product line. Launched in 2010 and domiciled in Ireland with primary listing in Germany, the fund operates globally but targets institutional and retail investors in Europe compliant with UCITS regulations. The fund's core offerings include physical and synthetic ETF variants under the Xtrackers brand managed by DWS Group, a subsidiary of Deutsche Bank AG headquartered in Frankfurt, Germany; these encompass equity index tracking across developed and emerging markets, fixed income, commodities, and multi-asset strategies. Xtrackers ETFs emphasize low-cost, efficient replication methods such as optimized sampling, direct holdings, or swaps to minimize tracking error and provide tax-efficient vehicles for portfolio construction. In recent developments, the ETF has benefited from sustained inflows amid strong U.S. equity market performance in 2024-2025, with assets under management surpassing EUR 10 billion as of late 2025; DWS announced enhancements to its UCITS ETF platform including expanded ESG-screened variants and improved swap counterparty diversification in Q3 2025 to address regulatory scrutiny on synthetic replication. No major acquisitions or rebranding occurred, but the fund integrated updated S&P 500 methodology changes reflecting free-float adjustments and quarterly rebalances. These updates align with DWS's strategic focus on scaling passive products amid rising European demand for U.S. exposure.